170 related articles for article (PubMed ID: 21655136)
1. Outcomes and cost-effectiveness of two nicotine replacement treatment delivery models for a tobacco quitline.
Saul JE; Lien R; Schillo B; Kavanaugh A; Wendling A; Luxenberg M; Greenseid L; An LC
Int J Environ Res Public Health; 2011 May; 8(5):1547-59. PubMed ID: 21655136
[TBL] [Abstract][Full Text] [Related]
2. Randomised trial of two nicotine patch protocols distributed through a state quitline.
Burns EK; Hood NE; Goforth E; Levinson AH
Tob Control; 2016 Mar; 25(2):218-23. PubMed ID: 25416755
[TBL] [Abstract][Full Text] [Related]
3. Impact of a Temporary NRT Enhancement in a State Quitline and Web-Based Program.
Cole S; Suter C; Nash C; Pollard J
Am J Health Promot; 2018 Jun; 32(5):1206-1213. PubMed ID: 27810948
[TBL] [Abstract][Full Text] [Related]
4. Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy.
An LC; Schillo BA; Kavanaugh AM; Lachter RB; Luxenberg MG; Wendling AH; Joseph AM
Tob Control; 2006 Aug; 15(4):286-93. PubMed ID: 16885577
[TBL] [Abstract][Full Text] [Related]
5. Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks.
McAfee TA; Bush T; Deprey TM; Mahoney LD; Zbikowski SM; Fellows JL; McClure JB
Am J Prev Med; 2008 Aug; 35(2):103-10. PubMed ID: 18617079
[TBL] [Abstract][Full Text] [Related]
6. Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.
Smith SS; Keller PA; Kobinsky KH; Baker TB; Fraser DL; Bush T; Magnusson B; Zbikowski SM; McAfee TA; Fiore MC
Nicotine Tob Res; 2013 Mar; 15(3):718-28. PubMed ID: 22992296
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline.
Hollis JF; McAfee TA; Fellows JL; Zbikowski SM; Stark M; Riedlinger K
Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i53-9. PubMed ID: 18048633
[TBL] [Abstract][Full Text] [Related]
8. Offering free NRT through a tobacco quitline: impact on utilisation and quit rates.
Tinkelman D; Wilson SM; Willett J; Sweeney CT
Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i42-6. PubMed ID: 18048631
[TBL] [Abstract][Full Text] [Related]
9. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
10. Impact and Effectiveness of a Stand-Alone NRT Starter Kit in a Statewide Tobacco Cessation Program.
Kerr AN; Schillo BA; Keller PA; Lachter RB; Lien RK; Zook HG
Am J Health Promot; 2019 Feb; 33(2):183-190. PubMed ID: 29747516
[TBL] [Abstract][Full Text] [Related]
11. Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial.
Cummins S; Zhu SH; Gamst A; Kirby C; Brandstein K; Klonoff-Cohen H; Chaplin E; Morris T; Seymann G; Lee J
Trials; 2012 Aug; 13():128. PubMed ID: 22853197
[TBL] [Abstract][Full Text] [Related]
12. Costs of giving out free nicotine patches through a telephone quit line.
Cummings KM; Hyland A; Carlin-Menter S; Mahoney MC; Willett J; Juster HR
J Public Health Manag Pract; 2011; 17(3):E16-23. PubMed ID: 21464679
[TBL] [Abstract][Full Text] [Related]
13. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
[TBL] [Abstract][Full Text] [Related]
15. The impact of a free nicotine patch starter kit on quit rates in a state quit line.
Bush TM; McAfee T; Deprey M; Mahoney L; Fellows JL; McClure J; Cushing C
Nicotine Tob Res; 2008 Sep; 10(9):1511-6. PubMed ID: 19023843
[TBL] [Abstract][Full Text] [Related]
16. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
17. Expanding access to nicotine replacement therapy through Minnesota's QUITLINE partnership.
Schillo BA; Wendling A; Saul J; Luxenberg MG; Lachter R; Christenson M; An LC
Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i37-41. PubMed ID: 18048630
[TBL] [Abstract][Full Text] [Related]
18. Using a quitline plus low-cost nicotine replacement therapy to help disadvantaged smokers to quit.
Miller CL; Sedivy V
Tob Control; 2009 Apr; 18(2):144-9. PubMed ID: 19131454
[TBL] [Abstract][Full Text] [Related]
19. QuitNic: A Pilot Randomized Controlled Trial Comparing Nicotine Vaping Products With Nicotine Replacement Therapy for Smoking Cessation Following Residential Detoxification.
Bonevski B; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Chiu S; Guillaumier A; Lubman DI
Nicotine Tob Res; 2021 Feb; 23(3):462-470. PubMed ID: 32770246
[TBL] [Abstract][Full Text] [Related]
20. Nicotine replacement therapy for smoking cessation.
Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
